Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy

No abstract is available for this paper.

• Publication year

  2008

• Venue

  AIDS (London)

• Publication date

  2008-09-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/QAD.0b013e32830b3a96PMID 18753860
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of genetic polymorphisms on the risk of lipid disorders in patients on anti-HIV therapy

  2007cited by this paper
• Current Clinical Issues Impacting the Lives of Patients Living With HIV/AIDS

  2007cited by this paper
• The clinical implications of antiretroviral pharmacogenomics.

  2006cited by this paper
• Metabolic and morphologic complications of HIV infection.

  2006cited by this paper
• Adrenergic receptor polymorphisms and autonomic nervous system function in human obesity.

  2006cited by this paper
• Metabolic and cardiovascular complications of highly active antiretroviral therapy for HIV infection.

  2006cited by this paper
• Cardiovascular disease in HIV infection.

  2006cited by this paper
• Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy.

  2006cited by this paper
• Associations among Race/Ethnicity, ApoC-III Genotypes, and Lipids in HIV-1-Infected Individuals on Antiretroviral Therapy

  2006cited by this paper
• Increased intramyocellular lipid accumulation in HIV-infected women with fat redistribution.

  2006cited by this paper
• HIV-associated lipodystrophy syndrome: an accelerated form of the metabolic syndrome of insulin resistance due to altered fat distribution.

  2006cited by this paper
• Reviewing the cardiovascular complications of HIV infection after the introduction of highly active antiretroviral therapy.

  2005cited by this paper
• Genetic polymorphisms of Fas (CD95) and Fas ligand (CD178) influence the rise in CD4+ T cell count after antiretroviral therapy in drug-naïve HIV-positive patients

  2005cited by this paper
• Antiretroviral-therapy-associated lipoatrophy: current status and future directions.

  2005cited by this paper
• beta-Blockade and increased dyslipidemia in patients bearing Glu27 variant of beta2 adrenergic receptor gene.

  2005cited by this paper
• Fat cells: afferent and efferent messages define new approaches to treat obesity.

  2005cited by this paper
• Association of adipose tissue deposition and beta-2 adrenergic receptor variants: the IRAS family study

  2005cited by this paper
• Interactive effects between polymorphisms in the beta-adrenergic receptors and longitudinal changes in obesity.

  2005cited by this paper
• Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine

  2005cited by this paper
• Association of Apolipoproteins C3 and E with Metabolic Changes in HIV-Infected Adults Treated with a Protease-Inhibitor-Containing Antiretroviral Therapy

  2005cited by this paper
• Tryptophan 64 → arginine polymorphism of β‐3‐adrenergic receptor in Chilean women with polycystic ovary syndrome

  2005cited by this paper
• β-Blockade and increased dyslipidemia in patients bearing Glu27 variant of β2 adrenergic receptor gene

  2005cited by this paper
• Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders.

  2005cited by this paper
• Haplotype Analysis of the β2 Adrenergic Receptor Gene and Risk of Myocardial Infarction in Humans

  2005cited by this paper
• Population prevalence of APOE, APOC3 and PPAR-α mutations associated to hypertriglyceridemia in French Canadians

  2004cited by this paper
• Beta-adrenoceptor polymorphisms.

  2004cited by this paper
• Inhibition of death-receptor mediated apoptosis in human adipocytes by the insulin-like growth factor I (IGF-I)/IGF-I receptor autocrine circuit.

  2004cited by this paper
• Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?

  2004cited by this paper
• Exon 6 and 2 peroxisome proliferator-activated receptor-gamma polymorphisms in polycystic ovary syndrome.

  2003cited by this paper
• Cardiovascular Risk Factors in HIV-Infected Patients

  2003cited by this paper
• Obesity risk is associated with carbohydrate intake in women carrying the Gln27Glu beta2-adrenoceptor polymorphism.

  2003cited by this paper
• AIDS-Related Lipodystrophy/Insulin Resistance Syndrome

  2003cited by this paper
• The Gly16-->Arg16 and Gln27-->Glu27 polymorphisms of beta2-adrenergic receptor are associated with metabolic syndrome in men.

  2003cited by this paper
• Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease Published, JLR Papers in Press, October 16, 2003. DOI 10.1194/jlr.M300253-JLR200

  2003cited by this paper
• Gender Differences in Antiretroviral Drug–Related Adipose Tissue Alterations: Women Are at Higher Risk Than Men and Develop Particular Lipodystrophy Patterns

  2003cited by this paper
• HIV lipodystrophy: risk factors, pathogenesis, diagnosis and management

  2003cited by this paper
• β-Adrenoceptor polymorphisms

  2003cited by this paper
• Incidence of adipose tissue alterations in first-line antiretroviral therapy: the LipoICoNa Study.

  2002cited by this paper
• TNF-α promoter region gene polymorphisms in HIV-positive patients with lipodystrophy

  2002cited by this paper
• A functional polymorphism in fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosus.

  2002cited by this paper
• β2-Adrenergic receptor mutation and abdominal obesity risk: Effect modification by gender and HDL-cholesterol

  2002cited by this paper
• Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study.

  2002cited by this paper
• Correlates of Risk of Adipose Tissue Alterations and Their Modifications over Time in HIV-1-Infected Women Treated with Antiretroviral Therapy

  2002cited by this paper
• TNF-alpha promoter region gene polymorphisms in HIV-positive patients with lipodystrophy.

  2002cited by this paper
• Association of BMI with the beta3-adrenergic receptor gene polymorphism in Japanese: meta-analysis.

  2001cited by this paper
• The peripheral sympathetic nervous system in human obesity

  2001cited by this paper
• PPARgamma and inflammatory bowel disease: a new therapeutic target for ulcerative colitis and Crohn's disease.

  2001cited by this paper
• Metabolic complications associated with antiretroviral therapy.

  2001cited by this paper
• PPARγ and inflammatory bowel disease: a new therapeutic target for ulcerative colitis and Crohn's disease

  2001cited by this paper
• Beta(2)-adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes.

  2001cited by this paper
• Beta3-adrenergic receptor polymorphism and the antiretroviral therapy-related lipodystrophy syndrome.

  2000cited by this paper
• Lipodystrophy Syndrome in HIV Infection

  2000cited by this paper
• Plasma Viral Load Concentrations in Women and Men From Different Exposure Categories and With Known Duration of HIV Infection

  2000cited by this paper
• The sympathetic nervous system and obesity: role in aetiology and treatment

  2000cited by this paper
• Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients

  2000cited by this paper
• The Gln27Glu beta2-adrenergic receptor variant is associated with obesity due to subcutaneous fat accumulation in Japanese men.

  1999cited by this paper
• The different effects of a Gln27Glu β2‐adrenoceptor gene polymorphism on obesity in males and in females

  1999cited by this paper
• Association of polymorphisms in the β2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus (Short Communication)

  1999cited by this paper
• Evaluation of a new Apo-1/Fas promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus patients.

  1999cited by this paper
• Association of polymorphisms in the beta2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus.

  1999cited by this paper
• Peroxisome proliferator-activated receptor γ C161→T polymorphism and coronary artery disease

  1999cited by this paper
• Peroxisome proliferator-activated receptor gamma C161-->T polymorphism and coronary artery disease.

  1999cited by this paper
• Polymorphism of the human beta3-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function.

  1999cited by this paper
• Polymorphism in the 5'-leader cistron of the beta2-adrenergic receptor gene associated with obesity and type 2 diabetes.

  1999cited by this paper
• A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity

  1998cited by this paper
• Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function.

  1997cited by this paper
• Transcription, adipocyte differentiation, and obesity

  1996cited by this paper
• Triglyceride-rich lipoproteins and the progression of coronary artery disease.

  1995cited by this paper
• Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns.

  1995cited by this paper
• Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity.

  1995cited by this paper
• Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia.

  1995cited by this paper
• Genetic Variation in the β3-Adrenergic Receptor and an Increased Capacity to Gain Weight in Patients with Morbid Obesity

  1995cited by this paper
• Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene.

  1995cited by this paper
• Regional adiposity and morbidity.

  1994cited by this paper
• Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.

  1985cited by this paper

• Association between the APOC3 (rs2854116), ESR2 (rs3020450), HFE (rs1799945), and MMP1 (rs1799750) gene polymorphisms and lipodystrophy in people living with HIV receiving antiretroviral therapy

  2025cites this paper
• Effect of genetic variations in drug transporters, metabolizing enzyme and regulatory genes on the development of HIV‐associated lipodystrophy

  2023cites this paper
• Will the Use of Pharmacogenetics Improve Treatment Efficiency in COVID-19?

  2022cites this paper
• Considerations into pharmacogenomics of COVID-19 pharmacotherapy: Hope, hype and reality

  2022cites this paper
• Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies

  2022cites this paper
• Pharmacogenomics and COVID-19: clinical implications of human genome interactions with repurposed drugs

  2021cites this paper
• BMPR2 promotes fatty acid oxidation and protects white adipocytes from cell death in mice

  2020cites this paper
• Association of the polymorphisms of the genes APOC3 (rs2854116), ESR2 (rs3020450), HFE (rs1799945), MMP1 (rs1799750) and PPARG (rs1801282) with lipodystrophy in people living with HIV on antiretroviral therapy: a systematic review

  2020cites this paper
• BMPR2 promotes fatty acid oxidation and protects white adipocytes from cell death in mice

  2020cites this paper
• AIDS/HPA Axis - Endotext - NCBI Bookshelf

  2019cites this paper
• Low prevalence of lipodystrophy in HIV-infected Senegalese children on long-term antiretroviral treatment: the ANRS 12279 MAGGSEN Pediatric Cohort Study

  2018cites this paper
• Ageing and inflammation in patients with HIV infection

  2017cites this paper
• Association of immune recovery with hyperlipidaemia and apolipoprotein gene polymorphisms following highly active antiretroviral therapy in a cohort of Chinese HIV patients

  2016cites this paper
• Body Composition Changes After Initiation of Raltegravir or Protease Inhibitors: ACTG A5260s.

  2016cites this paper
• Getting to 90-90-90 in paediatric HIV: What is needed?

  2015cites this paper
• Heterogeneity in Nutritional and Lipid Profiles in Children and Adolescents with Human Immunodeficiency Virus Treated with Highly Active Antiretroviral Therapy

  2015cites this paper
• Pharmacogenetics as a tool to tailor antiretroviral therapy: A review.

  2015cites this paper
• The physical and psychological effects of HIV infection and its treatment on perinatally HIV-infected children

  2015cites this paper
• Genome-Wide Association Study of HIV-Related Lipoatrophy in Thai Patients: Association of a DLGAP1 Polymorphism with Fat Loss

  2015cites this paper
• Genetic Variants of APOC3 Promoter and HLA-B Genes in an HIV Infected Cohort in Northern South Africa: A Pilot Study

  2014influential citation
• DNA methylation patterns are associated with n-3 fatty acid intake in Yup'ik people.

  2014cites this paper
• Differential Subcutaneous Adipose Tissue Gene Expression Patterns in a Randomized Clinical Trial of Efavirenz or Lopinavir-Ritonavir in Antiretroviral-Naive Patients

  2014cites this paper
• Lipodystrophy: The Metabolic Link of HIV Infection with Insulin-Resistance Syndrome

  2013cites this paper
• Lipoatrophy in HIV-infected children on antiretroviral therapy

  2013influential citation
• Polymorphisms in Fas Gene Is Associated with HIV-Related Lipoatrophy in Thai Patients

  2013influential citation
• Biceps Skin-fold Thickness May Detect and Predict Early Lipoatrophy in HIV-infected Children

  2013cites this paper
• Perinatally HIV‐Infected Adolescents

  2013cites this paper
• Metabolic complications and treatment of perinatally HIV-infected children and adolescents

  2013cites this paper
• Pharmacogenomic Aspects of Antiretroviral Therapy

  2012cites this paper
• High prevalence of lipoatrophy in pre-pubertal South African children on antiretroviral therapy: a cross-sectional study

  2012cites this paper
• Effects of PPARγ and RBP4 Gene Variants on Metabolic Syndrome in HIV-Infected Patients with Anti-Retroviral Therapy

  2012cites this paper
• Genetic polymorphisms in estrogen receptors and sexual dimorphism in fat redistribution in HIV-infected patients on HAART

  2012cites this paper
• Fat redistribution syndromes associated with HIV-1 infection and combination antiretroviral therapy.

  2012cites this paper
• Polymorphisms in Candidate Genes and Lipodystrophy and Dyslipidemia

  2012cites this paper
• Peroxisome Proliferator Activating Receptor Alpha and Gamma Polymorphisms and Metabolic Abnormalities in HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy: The ANRS CO8 APROCO-COPILOTE Study

  2012cites this paper
• Mitochondrial DNA Haplogroups and Incidence of Lipodystrophy in HIV-Infected Patients on Long-Term Antiretroviral Therapy

  2012cites this paper
• Management of Fat Accumulation in Patients with HIV Infection

  2011cites this paper
• Lessons from HIV Lipodystrophy and Drug-Induced Metabolic Dysfunction

  2011cites this paper
• Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons.

  2011cites this paper
• Genes linked to energy metabolism and immunoregulatory mechanisms are associated with subcutaneous adipose tissue distribution in HIV-infected men

  2011cites this paper
• Adipogenic gene variants in patients with HIV-associated lipodystrophy

  2011cites this paper
• Disorders of fat partitioning in treated HIV-infection.

  2011cites this paper
• The Effect of Polymorphisms in Candidate Genes on the Long-Term Risk of Lipodystrophy and Dyslipidemia in HIV-Infected White Patients Starting Antiretroviral Therapy

  2011influential citation
• Tesamorelin: a novel therapeutic option for HIV/HAART-associated increased visceral adipose tissue.

  2011cites this paper
• Pharmacogenetics of the lipodystrophy syndrome associated with HIV infection and combination antiretroviral therapy

  2011influential citation
• Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011.

  2011cites this paper
• Antiretroviral treatment-induced dyslipidemia in HIV-infected patients is influenced by the APOC3-related rs10892151 polymorphism

  2011cites this paper
• Growth hormone and HIV infection: contribution to disease manifestations and clinical implications.

  2011cites this paper
• CHAPTER 38 – Endocrinology of HIV/AIDS

  2011cites this paper
• HIV-associated lipodystrophy: from fat injury to premature aging.

  2010cites this paper
• New and emerging agents in the management of lipodystrophy in HIV-infected patients

  2010cites this paper
• Dyslipidemia in HIV-infected individuals: from pharmacogenetics to pharmacogenomics.

  2010cites this paper
• A fas gene polymorphism influences herpes simplex virus type 2 infection in South African women

  2010cites this paper
• Lipodistròfia en pacients infectats pel vih tractats amb fàrmacs antiretrovirals: determinants genètics i moleculars.

  2010cites this paper
• The MMP1 (−16071G/2G) single nucleotide polymorphism associates with the HAART-related lipodystrophic syndrome

  2010cites this paper
• New and emerging agents in the management of lipodystrophy in HIV-infected patients

  2010cites this paper
• Pharmacogenetics of the metabolic disturbances and atherosclerosis associated with antiretroviral therapy in HIV-infected patients.

  2010cites this paper
• Pharmacogenetics of antiretrovirals.

  2010cites this paper
• Pharmacogenetics of adverse effects due to antiretroviral drugs.

  2010cites this paper
• Personalizing antiretroviral therapy: is it a reality?

  2009cites this paper
• PPARγ Pro12Ala Polymorphism in HIV-1-Infected Patients with HAARTRelated Lipodystrophy

  2009cites this paper